{"id":57172,"date":"2017-03-23T08:56:31","date_gmt":"2017-03-23T12:56:31","guid":{"rendered":"http:\/\/www.hedgeco.net\/news\/?p=57172"},"modified":"2017-03-23T08:56:31","modified_gmt":"2017-03-23T12:56:31","slug":"biogen-wins-ruling-in-tecfidera-ip-case-shares-rise","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/03\/2017\/biogen-wins-ruling-in-tecfidera-ip-case-shares-rise.html","title":{"rendered":"Biogen Wins Ruling in Tecfidera IP Case; Shares Rise"},"content":{"rendered":"<p>\n(Reuters) Biogen Inc on Tuesday won an intellectual property rights ruling against hedge fund manager Kyle Bass over its top multiple sclerosis pill, Tecfidera, pushing shares up more than 1 percent on a day when most U.S. stocks were down. The ruling came from the U.S. Patent and Trademark Office&#8217;s Patent Trial and Appeal Board in Washington.<\/p>\n<p><a href=\"http:\/\/www.reuters.com\/article\/biogen-patent-idUSL2N1GZ201\">To read this article:<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Reuters) Biogen Inc on Tuesday won an intellectual property rights ruling against hedge fund manager Kyle Bass over its top multiple sclerosis pill, Tecfidera, pushing shares up more than 1 percent on a day when most U.S. stocks were down. [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-57172","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/57172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=57172"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/57172\/revisions"}],"predecessor-version":[{"id":57173,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/57172\/revisions\/57173"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=57172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=57172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=57172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}